                         SEQUENCE LISTING

<110>  Janssen Biotech, Inc.
 
<120>  SIALYLATED GLYCOPROTEINS

<130>  14131-0233WO1

<150>  US 63/068098
<151>  2020-08-20

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  To quantify glycopeptides for IgG1

<400>  1

Glu Glu Gln Tyr Asn Ser Thr Tyr Arg 
1               5                   


<210>  2
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  To quantify glycopeptides for IgG2/3

<400>  2

Glu Glu Gln Phe Asn Ser Thr Phe Arg 
1               5                   


<210>  3
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  To quantify glycopeptides for IgG3/4

<400>  3

Glu Glu Gln Tyr Asn Ser Thr Phe Arg 
1               5                   


<210>  4
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  To quantify glycopeptides for IgG3/4

<400>  4

Glu Glu Gln Phe Asn Ser Thr Tyr Arg 
1               5                   


